CARISMA Therapeutics Inc (OTCPK:CARM)
$ 0.0025 (0%) Market Cap: 105,000.00 Enterprise Value: -1.91 Mil PE Ratio: 0.01 PB Ratio: 0 GF Score: 0/100

Q3 2019 Sesen Bio Inc Earnings Call Transcript

Nov 12, 2019 / 01:00PM GMT
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Sesen Bio 3Q 2019 Business Update Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Senior Director, Strategic Planning, Dr. Chad Myskiw. Please go ahead, sir.

Chad Myskiw
Sesen Bio, Inc. - Senior Director of Strategic Planning

Thank you and good morning. Welcome to today's conference call to discuss our third quarter business update and upcoming milestones. On the call with me today are Dr. Thomas Cannell, President and CEO; and Monica Forbes, Chief Financial Officer.

Earlier this morning, we issued a press release outlining our third quarter 2019 financial results. The press release and the slides to which we will refer are available on the Investors section of the company's website at sesenbio.com.

Today's discussion will include forward-looking statements related to the company's current plans and expectations, which

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot